Health Condition 1: E282- Polycystic ovarian syndrome
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Both married /unmarried patients. Diagnosed cases as per ASRM (American society for reproductive medicine)/ESHRE (European society of human reproduction and embryology) criteria for PCOS. Patient willing to give written informed consent by themselves BMI less than or equal to 25 kg/m2
Exclusion criteria
Exclusion criteria: Patients suffering from chronic pelvic diseases like (Endometriosis, Pelvic Inflammatory Disease, Uterine Fibroid, Menorrhagia, extra), Organic lesions of reproductive tract like Tuberculosis, Carcinoma and congenital deformities and Sexually Transmitted Diseases, Patients with history of cardiac diseases, uncontrolled hypertension (Systolic Blood Pressure above 160 & Diastolic above 100mmhg), uncontrolled Diabetes Mellitus (Fasting Blood Sugar- above the range of 160 mg/dl).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected that trial drugs will help in the reduction of ovarian volume and induce ovulation. Timepoint: It is expected that trial drugs will help in the reduction of ovarian volume and induce ovulation at 8 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Regulation of menstrual pattern and reduction in hyperandrogenism (clinical/biochemical), improvement of the general health and QOL.Timepoint: 60 days | — |
Countries
India
Contacts
Institute of Teaching and Research in Ayurveda, INI, Jamnagar, Gujarat